Commonly used seizure drug could treat severe genetic liver disease

Friday, June 4, 2010 - 00:30 in Health & Medicine

The liver scarring of ±1-antitrypsin (AT) deficiency, the most common genetic cause for which children undergo liver transplantation, might be reversed or prevented with a medication long used to treat seizures, according to researchers. Because the anti-seizure drug is familiar to doctors and has a well-understood safety profile, clinical trials could begin immediately to see whether it can help affected patients.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net